2019/2825(RSP) Resolution on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole
Lead committee dossier:
Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | HAZEKAMP Anja ( GUE/NGL) | HOJSÍK Martin ( Renew) |
Lead committee dossier:
Legal Basis:
RoP 112-p2
Legal Basis:
RoP 112-p2Events
2019/10/10
EP - Motion for a resolution
Documents
2019/10/10
EP - Text adopted by Parliament, single reading
Documents
2019/10/10
EP - Decision by Parliament, 1st reading/single reading
Documents
2019/10/10
EP - End of procedure in Parliament
2019/09/12
EP - HAZEKAMP Anja (GUE/NGL) appointed as rapporteur in ENVI
Documents
- Motion for a resolution: B9-0103/2019
- Text adopted by Parliament, single reading: T9-0026/2019
- Decision by Parliament, 1st reading/single reading: T9-0026/2019
- Motion for a resolution: B9-0103/2019
- Text adopted by Parliament, single reading: T9-0026/2019
Activities
Votes
B9-0103/2019 - Proposition de résolution #
2019/10/10 Outcome: +: 402, -: 222, 0: 39
History
(these mark the time of scraping, not the official date of the change)
2020-01-19Show (4) Changes | Timetravel
docs/0/docs/0/url |
http://www.europarl.europa.eu/doceo/document/B-9-2019-0103_EN.html
|
docs/1 |
|
events/0 |
|
events/0 |
|
2019-10-14Show (3) Changes | Timetravel
docs |
|
events |
|
procedure/stage_reached |
Old
Awaiting Parliament 1st reading / single reading / budget 1st stageNew
Procedure completed |
2019-10-12Show (1) Changes | Timetravel
forecasts |
|
2019-10-11Show (1) Changes | Timetravel
forecasts/0/title |
Old
Vote in plenary scheduledNew
Vote scheduled |
2019-10-10Show (2) Changes
forecasts/0/title |
Old
Indicative plenary sitting date, 1st reading/single readingNew
Vote in plenary scheduled |
procedure/title |
Old
Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354)New
Resolution on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole |